VANCOUVER, British Columbia, Jan. 18, 2019 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that CSPA Group, Inc. ("CSPA") was issued an Annual Manufacturing License by the California Department of Public Health.
CSPA Group Inc. has now advanced its temporary manufacturing license status to an annual manufacturing license issued by the California Department of Public Health which became effective on Wednesday, January 16, 2019.
The Final Text of the Regulations promulgated by the California Department of Public Health and the Bureau of Cannabis Control was approved by the Office of Administrative Law on January 16, 2019. CSPA and its advisors and legal team are currently reviewing the changes and additions to the regulations to ensure that all operations and the packaging for CannaStripsTM and other CSPA products will comply with the final regulations. The Company expects to have artwork and compliant labeling ready to deliver to the packaging printer next week to ensure a February 2019 delivery.
Lifestyle Delivery Systems Inc.'s CEO, Brad Eckenweiler, stated, "The Annual Manufacturing License is another significant milestone that separates CSPA Group from other manufacturers."
CSPA Group, Inc. is located in Adelanto, California and is a City permitted and State Licensed manufacturer and distributor/transporter in the California cannabis industry. CSPA Group manufactures extracted oils and distillates, producing CannaStripsTM under a license agreement with Lifestyle Delivery Systems Inc. a British Columbia company.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to any other form of delivery but also allows for inclusion of a wide spectrum of ingredients from over the counter medications to homeopathic, nutraceutical, vitamins and supplements. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
Lifestyle Delivery Systems Inc. Brad Eckenweiler CEO & Director
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.